1. Improving drug delivery for Alzheimer ’ s disease through nose-to-brain delivery using nanoemulsions, nanostructured lipid carriers (NLC) and in situ hydrogels;Cunha,2021
2. Alzheimer ’ s disease drug development pipeline;Cummings,2022
3. The amyloid cascade and Alzheimer ’ s disease therapeutics: theory versus observation;Castellani,2019
4. Cholinesterase inhibitors as Alzheimer ’ s therapeutics (Review);Sharma,2019
5. Intranasal therapeutic strategies for management of Alzheimer's disease;Sood;Journal of Drug Targeting,2014